• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.78% Nasdaq Down1.13%

    More On CVD

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Covance Inc. (CVD)

    -NYSE
    106.42 0.00(0.00%) Feb 18
    CompetitorsGet Competitors for:
    Direct Competitor Comparison 
    CVDCRLPVT1QIndustry
    Market Cap:6.06B3.71BN/A8.06B194.92M
    Employees:N/A8,60020036,100132.00
    Qtrly Rev Growth (yoy):N/A0.07N/A0.060.16
    Revenue (ttm): N/A1.36B1.47B14.33B39.44M
    Gross Margin (ttm):N/A0.39N/A0.370.45
    EBITDA (ttm):N/A312.63MN/A769.89M-2.87M
    Operating Margin (ttm): N/A0.16N/A0.16-0.05
    Net Income (ttm):N/A150.26M123.70M1387.20MN/A
    EPS (ttm):3.233.13N/A3.08N/A
    P/E (ttm):32.9525.18N/A21.9030.15
    PEG (5 yr expected):N/A1.45N/A1.571.14
    P/S (ttm):N/A2.72N/A1.913.38
     
    CRL = Charles River Laboratories International, Inc.
    Pvt1 = PPD DEVELOPMENT, LLC (privately held)
    Q = Quintiles Transnational Holdings Inc.
    Industry = Medical Laboratories & Research
    1 = As of 2010  

     
    News on Direct Competitors 

    Currency in .